Insurance - Specialty
Compare Stocks
2 / 10Stock Comparison
AMSF vs MMC
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
AMSF vs MMC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Specialty | Insurance - Brokers |
| Market Cap | $569M | $85.27B |
| Revenue (TTM) | $325M | $26.45B |
| Net Income (TTM) | $46M | $4.13B |
| Gross Margin | 47.6% | 42.3% |
| Operating Margin | 17.8% | 23.2% |
| Forward P/E | 14.4x | 16.9x |
| Total Debt | $491K | $21.86B |
| Cash & Equiv. | $62M | $2.40B |
AMSF vs MMC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMERISAFE, Inc. (AMSF) | 100 | 49.4 | -50.6% |
| Marsh & McLennan Co… (MMC) | 100 | 177.7 | +77.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMSF vs MMC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMSF is the clearest fit if your priority is value and dividends.
- Lower P/E (14.4x vs 16.9x)
- 8.4% yield, vs MMC's 1.8%
MMC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 19 yrs, beta 0.14, yield 1.8%
- Rev growth 7.6%, EPS growth 8.6%, 3Y rev CAGR 7.3%
- 209.8% 10Y total return vs AMSF's 31.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.6% revenue growth vs AMSF's 2.6% | |
| Value | Lower P/E (14.4x vs 16.9x) | |
| Quality / Margins | Combined ratio 0.8 vs AMSF's 0.8 (lower = better underwriting) | |
| Stability / Safety | Beta 0.14 vs AMSF's 0.23 | |
| Dividends | 8.4% yield, vs MMC's 1.8% | |
| Momentum (1Y) | -22.0% vs AMSF's -29.2% | |
| Efficiency (ROA) | 7.0% ROA vs AMSF's 5.6%, ROIC 15.2% vs 21.9% |
AMSF vs MMC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AMSF vs MMC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MMC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MMC is the larger business by revenue, generating $26.5B annually — 81.5x AMSF's $325M. Profitability is closely matched — net margins range from 15.6% (MMC) to 14.3% (AMSF).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $325M | $26.5B |
| EBITDAEarnings before interest/tax | $58M | $7.0B |
| Net IncomeAfter-tax profit | $46M | $4.1B |
| Free Cash FlowCash after capex | $8M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +47.6% | +42.3% |
| Operating MarginEBIT ÷ Revenue | +17.8% | +23.2% |
| Net MarginNet income ÷ Revenue | +14.3% | +15.6% |
| FCF MarginFCF ÷ Revenue | +2.5% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.3% | +11.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -8.5% | 0.0% |
Valuation Metrics
AMSF leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 42% valuation discount to MMC's 21.3x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than MMC's 16.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $569M | $85.3B |
| Enterprise ValueMkt cap + debt − cash | $508M | $104.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.27x | 21.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.42x | 16.89x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.11x |
| EV / EBITDAEnterprise value multiple | 8.53x | 15.96x |
| Price / SalesMarket cap ÷ Revenue | 1.80x | 3.49x |
| Price / BookPrice ÷ Book value/share | 2.30x | 6.38x |
| Price / FCFMarket cap ÷ FCF | 63.83x | 21.39x |
Profitability & Efficiency
AMSF leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
MMC delivers a 26.9% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $10 for AMSF. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMC's 1.62x. On the Piotroski fundamental quality scale (0–9), AMSF scores 7/9 vs MMC's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.7% | +26.9% |
| ROA (TTM)Return on assets | +5.6% | +7.0% |
| ROICReturn on invested capital | +21.9% | +15.2% |
| ROCEReturn on capital employed | +16.8% | +17.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.00x | 1.62x |
| Net DebtTotal debt minus cash | -$61M | $19.5B |
| Cash & Equiv.Liquid assets | $62M | $2.4B |
| Total DebtShort + long-term debt | $491,000 | $21.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 6.66x |
Total Returns (Dividends Reinvested)
MMC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MMC five years ago would be worth $13,645 today (with dividends reinvested), compared to $8,110 for AMSF. Over the past 12 months, MMC leads with a -22.0% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors MMC at 0.7% vs AMSF's -9.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -18.3% | -3.6% |
| 1-Year ReturnPast 12 months | -29.2% | -22.0% |
| 3-Year ReturnCumulative with dividends | -24.8% | +2.0% |
| 5-Year ReturnCumulative with dividends | -18.9% | +36.5% |
| 10-Year ReturnCumulative with dividends | +31.8% | +209.8% |
| CAGR (3Y)Annualised 3-year return | -9.1% | +0.7% |
Risk & Volatility
MMC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MMC is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than AMSF's 0.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MMC currently trades 73.8% from its 52-week high vs AMSF's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.23x | 0.14x |
| 52-Week HighHighest price in past year | $48.54 | $235.78 |
| 52-Week LowLowest price in past year | $29.42 | $170.37 |
| % of 52W HighCurrent price vs 52-week peak | +62.4% | +73.8% |
| RSI (14)Momentum oscillator 0–100 | 34.2 | 37.2 |
| Avg Volume (50D)Average daily shares traded | 212K | 2.7M |
Analyst Outlook
Evenly matched — AMSF and MMC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates AMSF as "Buy" and MMC as "Hold". Consensus price targets imply 46.9% upside for AMSF (target: $45) vs 18.8% for MMC (target: $207). For income investors, AMSF offers the higher dividend yield at 8.41% vs MMC's 1.75%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $44.50 | $206.75 |
| # AnalystsCovering analysts | 6 | 26 |
| Dividend YieldAnnual dividend ÷ price | +8.4% | +1.8% |
| Dividend StreakConsecutive years of raises | 0 | 19 |
| Dividend / ShareAnnual DPS | $2.55 | $3.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +1.1% |
MMC leads in 3 of 6 categories (Income & Cash Flow, Total Returns). AMSF leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
AMSF vs MMC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AMSF or MMC a better buy right now?
For growth investors, Marsh & McLennan Companies, Inc.
(MMC) is the stronger pick with 7. 6% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMSF or MMC?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus Marsh & McLennan Companies, Inc. at 21. 3x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 4x.
03Which is the better long-term investment — AMSF or MMC?
Over the past 5 years, Marsh & McLennan Companies, Inc.
(MMC) delivered a total return of +36. 5%, compared to -18. 9% for AMERISAFE, Inc. (AMSF). Over 10 years, the gap is even starker: MMC returned +209. 8% versus AMSF's +31. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMSF or MMC?
By beta (market sensitivity over 5 years), Marsh & McLennan Companies, Inc.
(MMC) is the lower-risk stock at 0. 14β versus AMERISAFE, Inc. 's 0. 23β — meaning AMSF is approximately 68% more volatile than MMC relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 162% for Marsh & McLennan Companies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMSF or MMC?
By revenue growth (latest reported year), Marsh & McLennan Companies, Inc.
(MMC) is pulling ahead at 7. 6% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: Marsh & McLennan Companies, Inc. grew EPS 8. 6% year-over-year, compared to -14. 5% for AMERISAFE, Inc.. Over a 3-year CAGR, MMC leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMSF or MMC?
Marsh & McLennan Companies, Inc.
(MMC) is the more profitable company, earning 16. 6% net margin versus 14. 9% for AMERISAFE, Inc. — meaning it keeps 16. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMC leads at 23. 8% versus 18. 6% for AMSF. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMSF or MMC more undervalued right now?
On forward earnings alone, AMERISAFE, Inc.
(AMSF) trades at 14. 4x forward P/E versus 16. 9x for Marsh & McLennan Companies, Inc. — 2. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 46. 9% to $44. 50.
08Which pays a better dividend — AMSF or MMC?
All stocks in this comparison pay dividends.
AMERISAFE, Inc. (AMSF) offers the highest yield at 8. 4%, versus 1. 8% for Marsh & McLennan Companies, Inc. (MMC).
09Is AMSF or MMC better for a retirement portfolio?
For long-horizon retirement investors, Marsh & McLennan Companies, Inc.
(MMC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 8% yield, +209. 8% 10Y return). Both have compounded well over 10 years (MMC: +209. 8%, AMSF: +31. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMSF and MMC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AMSF is a small-cap deep-value stock; MMC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.